// App-Quantinova.ai

SAT0430 (2018) : Assessment of acr and slicc classification criteria in the asia pacific lupus collaboration cohort

Researchers

Presenter

  • R. Kandane-Rathnayake

Principal Investigators

  • W. Louthrenoo

  • S.-F. Luo

  • Y.-J. Wu

  • A. Lateef

  • S. Sockalingam

  • S. Navarra

  • L. Zamora

  • L. Hamijoyo

  • Y. Katsumata

  • M. Harigai

  • M. Chan

  • S. O’Neill

  • F. Goldblatt

  • C.S. Lau

  • A. Hoi

  • M. Nikpour

  • E. Morand

Medical Centers

  • School of Clinical Sciences, Monash University, Melbourne, Australia

  • Chiang Mai University Hospital, Chiang Mai, Thailand

  • Chang Gung Memorial Hospital, Taipei, Taiwan

  • Chang Gung Memorial Hospital, Keelung, Taiwan, Province of China

  • National University Hospital Singapore, Singapore, Singapore

  • University of Malaya, Kuala Lumpur, Malaysia

  • University of Santo Tomas Hospital, Manila, Philippines

  • Universitas Padjadjaran, Bandung, Indonesia

  • Tokyo Women's Medical University, Tokyo, Japan

  • Tan Tock Seng Hospital, Tan Tock Seng, Singapore

  • Liverpool Hospital, Liverpool

  • Royal Adelaide Hospital and Flinders Medical Centre, Adelaide, Australia

  • The University of Hong Kong, Pokfulam, Hong Kong

  • St Vincent's Hospital, Melbourne, Australia

Locations

  • Australia

  • Thailand

  • Taiwan

  • China

  • Singapore

  • Malaysia

  • Philippines

  • Indonesia

  • Japan

  • United Kingdom

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

Disease

  • Lupus nephritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A